Newborn Screening for 5q Spinal Muscular Atrophy: Comparisons between Real-Time PCR Methodologies and Cost Estimations for Future Implementation Programs

• Váldodahkkit: Vanessa Luiza Romanelli Tavares (Dahkki), Frederico Monfardini (Dahkki), Naila Cristina Vilaça Lourenço (Dahkki), Katia Maria da Rocha (Dahkki), Karina Weinmann (Dahkki), Rita Pavanello (Dahkki), Mayana Zatz (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2021-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Since the approval of modifying therapies for Spinal Muscular Atrophy (SMA), several protocols aiming to screen <i>SMN1</i> homozygous deletion in a neonatal context have been published. However, no work has compared different methodologies along with detailed implementation costs for ce...